Biomarkers Inform Clinical Trials and Pathogenesis in Systemic Sclerosis

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-8-s1-i14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Participating in Trials Can Inform Better Clinical Practice

British Journal of Dermatology
DermatologyMedicine
2017English

Systemic Sclerosis Pathogenesis and Emerging Therapies, Beyond the Fibroblast

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Clinical Pattern of Systemic Sclerosis in Central Ukraine. Association Between Clinical Manifestations of Systemic Sclerosis and Hypertension

Reumatologia
RheumatologyAllergyImmunology
2018English

A Functional Genomic Meta-Analysis of Clinical Trials in Systemic Sclerosis: Toward Precision Medicine and Combination Therapy

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Novel Cardiovascular Biomarkers and Implications for Clinical Trials

Nature Clinical Practice Cardiovascular Medicine
2006English

Use of Biomarkers in ALS Drug Development and Clinical Trials

Brain Research
NeuroscienceNeurologyDevelopmental BiologyMolecular Biology
2015English

Clinical Trials in Pediatric Multiple Sclerosis: Pending Landscape and Challenges

Brain Disorders & Therapy
2014English

Rehabilitation in Multiple Sclerosis: Outcome Selection in Clinical Trials

International Journal of MS Care
NeurologySpecialized NursingAdvanced
1999English

Clinical Association of Serum Interleukin-17 Levels in Systemic Sclerosis: Is Systemic Sclerosis a Th17 Disease?

Journal of Dermatological Science
DermatologyBiochemistryMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy